Pasithea Therapeutics Corp. — All Filings
303 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
144
3
3/A
4
4/A
424B3
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEFC14A
DEL AM
DFAN14A
DRS
EFFECT
FWP
NT 10-Q
POS AM
PRE 14A
PREC14A
PRER14A
PRRN14A
S-1
S-1/A
S-1MEF
S-3
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-C
SC TO-I
SC TO-I/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | — | 0001213900-25-043621 | May 14, 2025 | May 12, 2025 |
| SCHEDULE 13G | — | 0001649553-25-000067 | May 12, 2025 | — |
| SCHEDULE 13G | — | 0001213900-25-042031 | May 12, 2025 | — |
| SCHEDULE 13G | — | 0001641172-25-009466 | May 9, 2025 | — |
| SCHEDULE 13G/A | — | 0001641172-25-009469 | May 9, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-040725 | May 7, 2025 | May 6, 2025 |
| 424B4 | PROSPECTUS | 0001213900-25-040438 | May 7, 2025 | — |
| EFFECT | — | 9999999995-25-001437 | May 6, 2025 | — |
| S-1 | REGISTRATION STATEMENT | 0001213900-25-038088 | May 1, 2025 | — |
| CORRESP | — | 0001213900-25-038336 | May 1, 2025 | — |
| CORRESP | — | 0001213900-25-038338 | May 1, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-035640 | Apr 25, 2025 | Apr 23, 2025 |
| UPLOAD | — | 0000000000-25-003922 | Apr 14, 2025 | — |
| DRS | — | 0001213900-25-029372 | Apr 7, 2025 | — |
| 10-K | ANNUAL REPORT | 0001013762-25-001646 | Mar 24, 2025 | Dec 31, 2024 |
| SCHEDULE 13D/A | — | 0001013762-25-000233 | Mar 6, 2025 | — |
| SCHEDULE 13G/A | — | 0001172661-25-001313 | Feb 14, 2025 | — |
| 424B5 | PROSPECTUS SUPPLEMENT | 0001213900-24-102905 | Nov 26, 2024 | — |
| 8-K | CURRENT REPORT | 0001213900-24-102903 | Nov 26, 2024 | — |
| SC 13G | — | 0001172661-24-005093 | Nov 14, 2024 | — |
| 10-Q | QUARTERLY REPORT | 0001213900-24-097496 | Nov 13, 2024 | Sep 30, 2024 |
| EFFECT | — | 9999999995-24-003176 | Oct 11, 2024 | — |
| 424B3 | PROSPECTUS | 0001213900-24-087331 | Oct 11, 2024 | — |
| UPLOAD | — | 0000000000-24-011508 | Oct 10, 2024 | — |
| CORRESP | — | 0001213900-24-086845 | Oct 10, 2024 | — |
| S-3 | REGISTRATION STATEMENT | 0001213900-24-085933 | Oct 7, 2024 | — |
| 8-K | CURRENT REPORT | 0001213900-24-083408 | Sep 30, 2024 | Sep 26, 2024 |
| 8-K | CURRENT REPORT | 0001213900-24-081982 | Sep 26, 2024 | — |
| 10-Q | QUARTERLY REPORT | 0001213900-24-068297 | Aug 13, 2024 | Jun 30, 2024 |
| 8-K | CURRENT REPORT | 0001213900-24-056205 | Jun 26, 2024 | — |
| 4 | — | 0001213900-24-053005 | Jun 14, 2024 | Jun 12, 2024 |
| DEF 14A | PROXY STATEMENT | 0001213900-24-046814 | May 28, 2024 | Jun 26, 2024 |
| ARS | FORM ARS | 0001213900-24-046820 | May 28, 2024 | Dec 31, 2023 |
| 8-K | CURRENT REPORT | 0001213900-24-043036 | May 14, 2024 | May 13, 2024 |
| 10-Q | QUARTERLY REPORT | 0001213900-24-042981 | May 14, 2024 | Mar 31, 2024 |
| 4/A | — | 0001213900-24-030962 | Apr 5, 2024 | Mar 1, 2024 |
| 4/A | — | 0001213900-24-030961 | Apr 5, 2024 | Mar 1, 2024 |
| 4/A | — | 0001213900-24-030957 | Apr 5, 2024 | Mar 1, 2024 |
| 4/A | — | 0001213900-24-030958 | Apr 5, 2024 | Mar 1, 2024 |
| 4/A | — | 0001213900-24-030959 | Apr 5, 2024 | Mar 1, 2024 |
| 4/A | — | 0001213900-24-030960 | Apr 5, 2024 | Mar 1, 2024 |
| 4/A | — | 0001213900-24-030963 | Apr 5, 2024 | Mar 1, 2024 |
| EFFECT | — | 9999999995-24-000824 | Apr 2, 2024 | — |
| S-8 | REGISTRATION STATEMENT | 0001213900-24-028001 | Mar 29, 2024 | — |
| 10-K | ANNUAL REPORT | 0001213900-24-027508 | Mar 29, 2024 | Dec 31, 2023 |
| POS AM | POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 | 0001213900-24-027522 | Mar 29, 2024 | — |
| 4 | — | 0001213900-24-019219 | Mar 1, 2024 | — |
| 4 | — | 0001213900-24-019220 | Mar 1, 2024 | — |
| 4 | — | 0001213900-24-019221 | Mar 1, 2024 | — |
| 4 | — | 0001213900-24-019222 | Mar 1, 2024 | — |